Production (Stage)
Baudax Bio, Inc.
BXRXQ
$0.0001
$0.000.00%
OTC PK
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 363.00K | 1.42M | 3.80M | 5.26M | 5.65M |
Total Receivables | -- | -- | -- | 335.00K | 313.00K |
Inventory | -- | -- | -- | 0.00 | 4.48M |
Prepaid Expenses | 975.00K | 444.00K | 305.00K | 753.00K | 832.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 1.34M | 1.86M | 4.11M | 6.35M | 11.27M |
|
|||||
Total Current Assets | 1.34M | 1.86M | 4.11M | 6.35M | 11.27M |
Net Property, Plant & Equipment | 6.55M | 6.72M | 1.00K | 704.00K | 1.24M |
Long-term Investments | 8.80M | 9.24M | 2.13M | 2.13M | 2.13M |
Goodwill | 8.80M | 9.24M | 2.13M | 2.13M | 2.13M |
Total Other Intangibles | 3.90M | 3.50M | -- | 0.00 | 2.00M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | 829.00K | 854.00K | 875.00K |
Total Assets | 20.58M | 21.32M | 7.07M | 10.03M | 17.51M |
|
|||||
Total Accounts Payable | 7.82M | 5.83M | 3.84M | 3.93M | 3.61M |
Total Accrued Expenses | 3.53M | 2.49M | 2.12M | 2.40M | 2.97M |
Short-term Debt | 1.00M | 1.00M | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.57M | 5.48M | 6.00M | 5.82M | 5.91M |
Total Finance Division Other Current Liabilities | 2.13M | 5.67M | 419.00K | 9.32M | 8.78M |
Total Other Current Liabilities | 2.13M | 5.67M | 419.00K | 9.32M | 8.78M |
Total Current Liabilities | 19.05M | 20.46M | 12.37M | 21.46M | 21.28M |
|
|||||
Total Current Liabilities | 19.05M | 20.46M | 12.37M | 21.46M | 21.28M |
Long-Term Debt | -- | -- | 1.43M | 1.52M | 2.18M |
Short-term Debt | 1.00M | 1.00M | -- | -- | -- |
Capital Leases | 2.53M | 2.30M | 574.00K | 598.00K | 628.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 202.00K | 202.00K | -- | 10.70M | 12.97M |
Total Liabilities | 21.78M | 22.96M | 14.38M | 34.27M | 37.05M |
|
|||||
Common Stock & APIC | 179.06M | 176.20M | 172.19M | 166.66M | 162.11M |
Retained Earnings | -189.30M | -186.88M | -179.50M | -190.90M | -181.65M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -10.24M | -10.68M | -7.31M | -24.24M | -19.54M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 9.04M | 9.04M | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 9.04M | 9.04M | -- | -- | -- |
|
|||||
Total Common Equity | -10.24M | -10.68M | -7.31M | -24.24M | -19.54M |
Total Preferred Equity | 9.04M | 9.04M | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -1.20M | -1.64M | -7.31M | -24.24M | -19.54M |
|